Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. - Wikidata - awgldk - TriplyDB

Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.

Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.

http://www.wikidata.org/entity/Q37722175

about

Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 13-05).Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study.Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study

P2860

Q33762053-9D5E4342-C44F-4D2D-A14A-0F0FCCC73FD3 Q35972469-3942E4AF-BACE-4997-8A58-592FEB79C5FB Q36052780-97A35D55-3764-43D5-8A4B-B3DAFBF0D0E3 Q37441574-DFF3A6D9-9BFD-47BF-B689-0B86E4BED1B9 Q40128040-853B642F-EB9E-47A3-8D30-70BF702AE248 Q48350251-43A09883-23E8-430B-835A-B92C5AE14B78 Q50042111-D72FC4DD-4FCE-4489-95BC-7B9B7BD09100 Q58772593-1F95DE90-BCC6-4BE8-BB14-AE3EA382FBDB

P2860

Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.

http://www.wikidata.org/entity/Q37722175

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical characteristics and p ...... with extrahepatic metastasis.

@en

Clinical characteristics and p ...... with extrahepatic metastasis.

@nl

type

label

Clinical characteristics and p ...... with extrahepatic metastasis.

@en

Clinical characteristics and p ...... with extrahepatic metastasis.

@nl

prefLabel

Clinical characteristics and p ...... with extrahepatic metastasis.

@en

Clinical characteristics and p ...... with extrahepatic metastasis.

@nl

P1433

Q37722175-EB42C4A5-C42E-4779-8959-F6D6F7A76910

P1476

Q37722175-EF863862-12B5-46F1-B1A0-7019A71FEEDC

P2093

Q37722175-1FB7776E-A21F-4E33-8282-E9B80670282C

Q37722175-4D947B19-13F4-4C4E-8514-DDC12669983D

Q37722175-53A9981F-9E1D-4C3C-B9D8-7B8FF0170542

Q37722175-5BB1CC3E-EAC9-4410-9F25-7615897FC95A

Q37722175-5E8E4871-E4AA-4AB7-BAB0-71296B8446EE

Q37722175-7B1FD67D-6E52-4A3A-A50A-6DC2E36478A9

Q37722175-7B7EBFFD-6ECA-4991-8687-172C99762C66

Q37722175-8184CF16-2D39-4BEB-B4F1-4EE8AE8A63D6

Q37722175-970DD4C4-0F21-441F-8118-101AE7A503D2

Q37722175-E91E46C6-1EB8-4552-B0F0-4428C92CFE45

P2860

Q37722175-0363F00F-2485-4425-8869-2D641E58216F

Q37722175-053A3D02-D8DD-498A-A387-7A342B822555

Q37722175-15136FA5-2D68-4EDD-8752-37B2029EA930

Q37722175-1E0DF820-CAB7-495E-93B0-DA9C26F08BF8

Q37722175-207A7E92-C33C-4970-8A3D-78E648DCF72C

Q37722175-25AE31EA-5284-4161-89C1-4816F75A1E88

Q37722175-25E583E5-2E5F-49EF-8CA3-ECE594307021

Q37722175-29D70827-AF1B-4C62-A5DB-CAC593A06860

Q37722175-2F88A28F-A113-459B-9FFB-60624F74DE86

Q37722175-30600AE5-03C4-4768-9C12-3A6282F2B5ED

P304

Q37722175-98B23A37-80EE-4948-8CA9-E740E3D43D5A

P31

Q37722175-A7F0B69A-30C9-433F-8F6F-2560CAF44821

P356

Q37722175-E6322B0F-DA03-4512-B397-301C152E6DA6

P433

Q37722175-FDC7D4E3-4FB4-4882-B60E-4E7D1FEEE388

P478

Q37722175-E8AF3751-C4E5-40CE-88BD-85E7B9574274

P50

Q37722175-05F43560-4621-4FF7-AEB9-DF0893CE893D

P577

Q37722175-9B197224-5F33-4016-8D6C-991373DD25EA

P698

Q37722175-DD478DFD-F073-44B9-86EA-A8A8D9016DC1

P932

Q37722175-26407AB2-4232-48EA-A173-E09F9F385DB4

P356

P1433

Molecular and clinical oncology

P1476

Clinical characteristics and p ...... a with extrahepatic metastasis

@en

P2093

Hajime Aino

http://www.w3.org/2001/XMLSchema#string

Hiroaki Sumie

http://www.w3.org/2001/XMLSchema#string

Manabu Satani

http://www.w3.org/2001/XMLSchema#string

Michio Sata

http://www.w3.org/2001/XMLSchema#string

Nobuyoshi Tajiri

http://www.w3.org/2001/XMLSchema#string

Ryoko Kuromatsu

http://www.w3.org/2001/XMLSchema#string

Shigeo Shimose

http://www.w3.org/2001/XMLSchema#string

Shingo Yamada

http://www.w3.org/2001/XMLSchema#string

Shuji Sumie

http://www.w3.org/2001/XMLSchema#string

Shusuke Okamura

http://www.w3.org/2001/XMLSchema#string

P2860

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Management of hepatocellular carcinoma: An update

Sorafenib in advanced hepatocellular carcinoma

Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.

Early hepatocellular carcinoma as an entity with a high rate of surgical cure.

Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations.

Systemic therapy for advanced hepatocellular carcinoma: a review.

P304

393-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2014.259

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Masahito Nakano

P577

2014-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24772306

http://www.w3.org/2001/XMLSchema#string

P932

3999133

http://www.w3.org/2001/XMLSchema#string